131 related articles for article (PubMed ID: 38607224)
1. Effects of Rifampicin Plus Levofloxacin or Isoniazid on Immune Function of Patients with Pulmonary Tuberculosis.
Lv F; Tang N
Altern Ther Health Med; 2024 Apr; ():. PubMed ID: 38607224
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial.
Laohapojanart N; Ratanajamit C; Kawkitinarong K; Srichana T
Pulm Pharmacol Ther; 2021 Oct; 70():102056. PubMed ID: 34273498
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety Analysis of Piperacillin Tazobactam in Combination With High Frequency Chest Wall Oscillation in Patients With COPD Coupled With Pneumonia.
Li L; Feng Q; Meng Q; Li F
Altern Ther Health Med; 2023 Jan; 29(1):124-129. PubMed ID: 35986739
[TBL] [Abstract][Full Text] [Related]
4. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19.
Tahseen S; Khanzada FM; Rizvi AH; Qadir M; Ghazal A; Baloch AQ; Mustafa T
PLoS One; 2020; 15(9):e0239328. PubMed ID: 32966321
[TBL] [Abstract][Full Text] [Related]
6. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
[TBL] [Abstract][Full Text] [Related]
7. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
Zhang L; Han X; Ge Q; Shu W; Sun Y; Gao J; Xie S; Wang J; Gao W
BMC Infect Dis; 2024 Jan; 24(1):7. PubMed ID: 38166793
[TBL] [Abstract][Full Text] [Related]
9. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014.
Cornejo Garcia JG; Alarcón Guizado VA; Mendoza Ticona A; Alarcon E; Heldal E; Moore DAJ
PLoS One; 2018; 13(12):e0206658. PubMed ID: 30513085
[TBL] [Abstract][Full Text] [Related]
11. [The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
Tan S; Ding X; Tan Y; Cai X; Li Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):915-8. PubMed ID: 25609129
[TBL] [Abstract][Full Text] [Related]
12. Principles of chemotherapy for tuberculosis in national tuberculosis programmes of low- and middle-income countries.
Chiang CY; Lin CJ
Indian J Tuberc; 2020 Dec; 67(4S):S16-S22. PubMed ID: 33308663
[TBL] [Abstract][Full Text] [Related]
13. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.
Pillay S; Steingart KR; Davies GR; Chaplin M; De Vos M; Schumacher SG; Warren R; Theron G
Cochrane Database Syst Rev; 2022 May; 5(5):CD014841. PubMed ID: 35583175
[TBL] [Abstract][Full Text] [Related]
14. Effects of Catheter Tracking Management on Urinary Tract Function and Infection Rates in Patients With Spinal Cord Injury.
Ruijuan Z; Li X; Yingjie W; Rui W; Chunqing L
Altern Ther Health Med; 2023 Apr; 29(3):104-109. PubMed ID: 36634314
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.
Dean AS; Zignol M; Cabibbe AM; Falzon D; Glaziou P; Cirillo DM; Köser CU; Gonzalez-Angulo LY; Tosas-Auget O; Ismail N; Tahseen S; Ama MCG; Skrahina A; Alikhanova N; Kamal SMM; Floyd K
PLoS Med; 2020 Jan; 17(1):e1003008. PubMed ID: 31961877
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Controlled, Phase III Clinical Trial to Evaluate the Efficacy and Tolerability of Risorine with Conventional Rifampicin in the Treatment of Newly Diagnosed Pulmonary Tuberculosis Patients.
Patel N; Jagannath K; Vora A; Patel M; Patel A
J Assoc Physicians India; 2017 Sep; 65(9):48-54. PubMed ID: 29313577
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Kalita J; Misra UK; Prasad S; Bhoi SK
J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957
[TBL] [Abstract][Full Text] [Related]
18. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
19. Exercise Plus Acupuncture on Consensus Acupoints Versus Acupoints Selected by the Theory of Equal Impact on Tendons, Bones, and Muscles for Knee Osteoarthritis.
Yang J; Lan X; Cai Q; Lu Z; Wang Y
Altern Ther Health Med; 2023 Jul; 29(5):262-267. PubMed ID: 37052974
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin.
Chan CH; Or KK; Cheung W; Woo J
J Med; 1995; 26(1-2):43-52. PubMed ID: 7561530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
